Early phase (day 1–day 3) profile and clinical significance of circulating miR-101 and miR-146a in adult sepsis
Özlem Aldemir, Hatun Öztürk Çerik, Burcu Bayyurt, Murtaza Öz · 2026
Read Early phase (day 1–day 3) profile and clinical significance of circulating miR-101 and miR-146a in adult sepsis by Özlem Aldemir, Hatun Öztürk Çerik, Burcu Bayyurt, Murtaza Öz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427249.txt.
Description
Aldemir and colleagues report a 2026 study of two microRNAs in the blood during the first three days of sepsis, the body's dangerous overreaction to infection. Fifteen adults meeting modern sepsis criteria and fifteen healthy controls gave blood on day one and day three. The team measured miR-101 and miR-146a, small RNA regulators of inflammation, and compared them with standard severity and inflammation markers.
On day one, miR-101 ran markedly higher in sepsis patients than in controls, a clear statistical gap. MiR-146a ran lower but not significantly. Neither marker changed much between day one and day three. MiR-101 tracked procalcitonin, a standard infection marker, in positive correlation. An early stable signal could help bedside judgments, though fifteen patients is pilot-sized.
Catalog record
| CREATOR | Özlem Aldemir, Hatun Öztürk Çerik, Burcu Bayyurt, Murtaza Öz |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |